Clinical Trials Directory

Trials / Completed

CompletedNCT00676286

Biological Investigations in Active Surveillance (BIAS) IGAR 2008 I 19 in Prostate Cancer Using High Field MRI (3 Tesla), PET, and Biomarkers

Biological Investigations in Active Surveillance (BIAS) IGAR 2008 I 19

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
26 (actual)
Sponsor
AHS Cancer Control Alberta · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will use high field MRI (3 Tesla), PET and biomarker to follow prostate cancers and determine if these tests can detect cancers that become aggressive.

Detailed description

This study may lead to the identification of additional investigations that can monitor for signs of disease progression in active surveillance protocols. This can directly benefit patients by providing them with greater confidence that their disease is being accurately monitored. In addition, this study may be beneficial to the general management of prostate cancers by adding to our knowledge of these investigations characterizing prostate cancers.

Conditions

Interventions

TypeNameDescription
PROCEDURE3T MR Imaging3TR Imaging
PROCEDUREC-Choline PET ScanningC-Choline PET Scanning
PROCEDUREGene RearrangementGene Rearrangement

Timeline

Start date
2008-11-01
Primary completion
2016-03-01
Completion
2016-03-01
First posted
2008-05-13
Last updated
2016-07-06

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00676286. Inclusion in this directory is not an endorsement.